Docs are excited about CAR-T, BTK drugs, post-ASH survey finds by Beth Snyder Bulik Tuesday, January 7, 2020 Physicians at ASH 2019 named multiple myeloma, diffuse large B-cell lymphoma and chronic lymphocytic leukemia as most exciting topics this year.
Exploring What Physicians Know and Don’t Know About Nucleic Acid-Based Medicines Presented by: InCrowd Wednesday, October 16, 2019 Explore nucleic acid-based medicines with industry experts, Dr. Melissa Moore, global messenger RNA (mRNA) expert and chief scientific officer of Moderna’s mRNA research platform, and Dr. Diane Hayes, InCrowd co-founder and board member.
Hey, pharma: Cut DTC and ramp up generics, docs suggest by Beth Snyder Bulik Thursday, February 21, 2019 When it comes to reducing drug prices, doctors think pharma should go on a DTC diet.
Ban DTC or fix it? Docs sound off about patient confusion over ads by Beth Snyder Bulik Monday, January 30, 2017 Confused by pharma ads? You’re not alone. Almost two-thirds of U.S. physicians say their patients don’t understand pharma DTC advertising.
Gartner’s new 'cool vendors' rule digital data connections by Beth Snyder Bulik Wednesday, May 4, 2016
